Oversight Slips into Permission as Big Insurance Outplays the Federal Watchdog

The federal government loves to say it “oversees” Big Insurance.

In reality, it often supervises from a safe distance while insurers engineer aggressive workarounds in plain sight. Chris Deacon’s latest Substack piece on Anthem’s Federal Employees Health Benefits Program contract reads like a sharp case study in how power quietly shifts from the regulator to the regulated.

FEHBP is the federal employee health program, but the day-to-day plan is run through the Blue Cross Blue Shield Association and its Blue plans, not directly by the government. Anthem is one of those Blue-branded plans, and Anthem, Inc. is now Elevance Health, which also owns Carelon.

It’s confusing by design, and we call it massive vertical integration. The HHS Office of Inspector General (OIG) found Anthem allegedly paid its sister company, Carelon, a percentage of subrogation recoveries, then labeled that cut as a health benefit expense instead of an administrative cost.

That reclassification matters because it can make overhead masquerade as “medical spending,” while quietly manufacturing a larger profit stream inside a federal contract that is supposed to limit that kind of profit.

Let’s pause on the OIG piece, because clinicians hear “OIG” and think: audits, exclusions, career-ending risk. Inspectors General exist because Congress created independent watchdog offices to audit and investigate federal programs, then report problems to agency leaders and Congress, with the goal of preventing fraud, waste and abuse.

The brand is intimidating. The enforcement, at least in this story, looks negotiable.

Deacon reports the OIG flagged $39.2M in subrogation fees and $5.6M in lost investment income, saying Anthem used a related company to take a cut the contract did not allow. Deacon also reports Anthem stalled the audit by withholding records and turning over only heavily redacted pages from a Deloitte report.

When a federal contractor can constrain an audit by withholding documentation, dispute the findings and keep moving, we are not watching regulation. We are watching negotiated permission.

That's not the end of the story. You can read its entirety here: https://lnkd.in/eeuKvYHP

So what is the government doing to rein in Big Insurance? In this example, nothing.

The OIG gap clinicians experience is not a lack of rules. It is a lack of urgency, clarity and penalties when payers treat “we disagree” as a strategy.

If the government truly has power over Big Insurance, it should use it.

Vertical integration didn’t just blur the lines here, it erased them: the insurer, the “vendor,” and the profit center sit under the same corporate roof. If OIG and government oversight is real, it has to come with non-negotiable transparency and immediate penalties, otherwise Big Insurance will keep writing the rules and the government will keep playing referee without a whistle.